53
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1887465
Synthica Biotech is a biopharmaceutical company that provides treatments to address unmet medical needs in dermato-oncological diseases.
- Silvio Traversa: Co-founder & CEO
About the Company
Synthica Biotech provides new effective options to address unmet medical needs in melanoma. Sintica has focused its first-line activities on melanoma, a serious form of skin cancer that begins in cells known as melanocytes. They provide treatment for melanoma is the most invasive skin cancer with the highest risk of death. Sintica has developed a
peptidomimetic, SNT001, addressing an unprecedented pharmacological target to induce apoptosis in melanoma cells.
